Articles overview
![](https://www.myelomaplatform.eu/wp-content/uploads/2023/01/article-tumbnail3-1024x1024.webp)
Hypogammaglobulinemia newsletter
Welcome to this edition of the Sanofi quarterly newsletter! These newsletters, created by Sanofi, aim to provide education to healthcare...
Read more
![](https://www.myelomaplatform.eu/wp-content/uploads/2023/01/article-tumbnail3-1024x1024.webp)
Risk stratification in patients with monoclonal Gammopathies
Thorsteinsdóttir, S., Gíslason, G., Aspelund, T. et al. Prevalence of smoldering multiple myeloma based on nationwide screening. Nature Medicine. 2023;...
Read more
![](https://www.myelomaplatform.eu/wp-content/uploads/2023/01/article-tumbnail3-1024x1024.webp)
Review: NK cell therapy in relapsed refractory multiple myeloma
Read the review about NK cell therapy in relaped refractory multiple Myeloma from Science direct
Read more
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/ijms-logo-social-1.webp)
Personalized Medicine
Patient-derived multiple myeloma 3D models for personalized medicine
Read more